Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact

Viewpoint

  • 82 Articles
  • 0 Posts
  • ← Previous
  • 1
  • 2
  • 3
  • 4
  • …
  • 8
  • 9
  • Next →
Prioritizing clinical research studies during the COVID-19 pandemic: lessons from New York City
Roy M. Gulick, … , Donald W. Landry, Anthony N. Hollenberg
Roy M. Gulick, … , Donald W. Landry, Anthony N. Hollenberg
Published July 21, 2020
Citation Information: J Clin Invest. 2020. https://doi.org/10.1172/JCI142151.
View: Text | PDF

Prioritizing clinical research studies during the COVID-19 pandemic: lessons from New York City

  • Text
  • PDF
Abstract

A retrospective look at how clinical research trials were prioritized in New York City in the wake of the COVID-19 pandemic provides insights for future clinical research efforts.

Authors

Roy M. Gulick, Magdalena E. Sobieszczyk, Donald W. Landry, Anthony N. Hollenberg

×

NIDDK initiatives addressing health disparities in chronic diseases
B. Tibor Roberts, Griffin P. Rodgers
B. Tibor Roberts, Griffin P. Rodgers
Published July 21, 2020
Citation Information: J Clin Invest. 2020. https://doi.org/10.1172/JCI141563.
View: Text | PDF

NIDDK initiatives addressing health disparities in chronic diseases

  • Text
  • PDF
Abstract

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) focuses on many diseases that place disparate burdens on minority groups and the poor, such as obesity, diabetes, and kidney disease. Here, we highlight the NIDDK's commitment to combating health disparities through basic, translational, and clinical research.

Authors

B. Tibor Roberts, Griffin P. Rodgers

×

Cannabis and the developing brain challenge risk perception
Yasmin L. Hurd
Yasmin L. Hurd
Published June 22, 2020
Citation Information: J Clin Invest. 2020. https://doi.org/10.1172/JCI139051.
View: Text | PDF

Cannabis and the developing brain challenge risk perception

  • Text
  • PDF
Abstract

Authors

Yasmin L. Hurd

×

Is innate immunity our best weapon for flattening the curve?
Leonard Angka, … , Michele Ardolino, Rebecca C. Auer
Leonard Angka, … , Michele Ardolino, Rebecca C. Auer
Published June 8, 2020
Citation Information: J Clin Invest. 2020. https://doi.org/10.1172/JCI140530.
View: Text | PDF

Is innate immunity our best weapon for flattening the curve?

  • Text
  • PDF
Abstract

Broadly activating innate immunity, which has been achieved via unrelated vaccines or Type-I INF-like factors, may effectively treat or prevent COVID-19 and future coronavirus diseases.

Authors

Leonard Angka, Marisa Market, Michele Ardolino, Rebecca C. Auer

×

The changing investment in translational science by academic medical centers: HOPE in the Valley of Death
Lucy Y. Ghoda, … , Steven T. Rosen, Larry W. Kwak
Lucy Y. Ghoda, … , Steven T. Rosen, Larry W. Kwak
Published June 2, 2020
Citation Information: J Clin Invest. 2020. https://doi.org/10.1172/JCI138640.
View: Text | PDF

The changing investment in translational science by academic medical centers: HOPE in the Valley of Death

  • Text
  • PDF
Abstract

Authors

Lucy Y. Ghoda, Steven T. Rosen, Larry W. Kwak

×

Venture capital in academia: does present reality call for more nonprofit venture?
David T. Ting, Julius J.S. Knowles
David T. Ting, Julius J.S. Knowles
Published June 2, 2020
Citation Information: J Clin Invest. 2020. https://doi.org/10.1172/JCI138642.
View: Text | PDF

Venture capital in academia: does present reality call for more nonprofit venture?

  • Text
  • PDF
Abstract

Authors

David T. Ting, Julius J.S. Knowles

×

Advancing progress for patients with cancer through small business innovation research
Norman E. Sharpless
Norman E. Sharpless
Published June 2, 2020
Citation Information: J Clin Invest. 2020. https://doi.org/10.1172/JCI138643.
View: Text | PDF

Advancing progress for patients with cancer through small business innovation research

  • Text
  • PDF
Abstract

Authors

Norman E. Sharpless

×

COVID-19, microangiopathy, hemostatic activation, and complement
Wen-Chao Song, Garret A. FitzGerald
Wen-Chao Song, Garret A. FitzGerald
Published May 27, 2020
Citation Information: J Clin Invest. 2020. https://doi.org/10.1172/JCI140183.
View: Text | PDF

COVID-19, microangiopathy, hemostatic activation, and complement

  • Text
  • PDF
Abstract

In COVID-19, complement activation may contribute to hemostatic activation leading to pathological features such as microvascular injury and coagulopathy.

Authors

Wen-Chao Song, Garret A. FitzGerald

×

Current and potential future applications of human stem cell models in drug development
Mark Donowitz, … , Alan S. Verkman, Nicholas Constantine Zachos
Mark Donowitz, … , Alan S. Verkman, Nicholas Constantine Zachos
Published May 26, 2020
Citation Information: J Clin Invest. 2020. https://doi.org/10.1172/JCI138645.
View: Text | PDF

Current and potential future applications of human stem cell models in drug development

  • Text
  • PDF
Abstract

Authors

Mark Donowitz, Jerrold R. Turner, Alan S. Verkman, Nicholas Constantine Zachos

×

What are the mechanisms underlying vaping-induced lung injury?
Laura E. Crotty Alexander, … , Amy L. Bellinghausen, Michelle N. Eakin
Laura E. Crotty Alexander, … , Amy L. Bellinghausen, Michelle N. Eakin
Published May 11, 2020
Citation Information: J Clin Invest. 2020. https://doi.org/10.1172/JCI138644.
View: Text | PDF

What are the mechanisms underlying vaping-induced lung injury?

  • Text
  • PDF
Abstract

Authors

Laura E. Crotty Alexander, Amy L. Bellinghausen, Michelle N. Eakin

×
  • ← Previous
  • 1
  • 2
  • 3
  • 4
  • …
  • 8
  • 9
  • Next →

No posts were found with this tag.

Advertisement
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts